Eagle Pharmaceuticals, Inc. Long-Term Debt, Maturity, after Year Five
Eagle Pharmaceuticals, Inc. had Long-Term Debt, Maturity, after Year Five of $0 as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2021-11-09
- 2021-09-30: Long-Term Debt, Maturity, after Year Five $0.00.
- 2021-06-30: Long-Term Debt, Maturity, after Year Five $0.00.
- 2021-03-31: Long-Term Debt, Maturity, after Year Five $0.00.
- 2020-09-30: Long-Term Debt, Maturity, after Year Five $0.00.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 |